BRITANNIA LIFE SCIENCES (F:L020) — Stock Price
BRITANNIA LIFE SCIENCES (F:L020) is currently trading at €0.03 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.03 and €0.07. This page tracks BRITANNIA LIFE SCIENCES's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is BRITANNIA LIFE SCIENCES worth.
BRITANNIA LIFE SCIENCES (L020) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BRITANNIA LIFE SCIENCES's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
BRITANNIA LIFE SCIENCES Income Statement — Revenue, Profit & Earnings by Year
BRITANNIA LIFE SCIENCES's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €369.28K | €516.83K | €6.40 Million | €7.30 Million |
| Cost of Revenue | €341.95K | €379.11K | €1.77 Million | €2.04 Million |
| Gross Profit | €27.33K | €137.72K | €4.64 Million | €5.26 Million |
| Research & Development | — | — | — | — |
| SG&A | €1.99 Million | €1.63 Million | €3.42 Million | €13.43 Million |
| Total Operating Expenses | €2.39 Million | €7.34 Million | €5.41 Million | €15.66 Million |
| Operating Income | €-2.02 Million | €-6.82 Million | €994.09K | €-8.36 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €106.17K | €98.44K | €853.79K | €2.31 Million |
| Income Before Tax | €-4.56 Million | €-6.12 Million | €5.86 Million | €-13.27 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €7.39 Million | €-4.77 Million | €5.08 Million | €-15.46 Million |
BRITANNIA LIFE SCIENCES Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BRITANNIA LIFE SCIENCES's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €11.61 Million | €22.26 Million | €23.55 Million | €21.09 Million |
| Total Current Assets | €9.93 Million | €2.73 Million | €4.22 Million | €3.48 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €228.11K | €1.21 Million | €1.60 Million | €1.79 Million |
| Inventory | €0.00 | €184.36K | €0.00 | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €0.00 | €17.78 Million | €17.38 Million | €17.06 Million |
| Total Liabilities | €5.31 Million | €15.59 Million | €12.49 Million | €15.61 Million |
| Total Current Liabilities | €3.65 Million | €10.50 Million | €4.60 Million | €8.32 Million |
| Long-term Debt | €1.54 Million | €4.76 Million | €6.29 Million | €122.49K |
| Net Debt | — | €5.55 Million | €5.68 Million | €3.38 Million |
| Total Stockholder Equity | €6.30 Million | €2.44 Million | €7.02 Million | €1.35 Million |
| Retained Earnings | €-13.29 Million | €-17.36 Million | €-11.94 Million | €-16.20 Million |
BRITANNIA LIFE SCIENCES Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BRITANNIA LIFE SCIENCES generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €-2.62 Million | €2.09 Million | €2.01 Million | €2.80 Million |
| Capital Expenditures | €0.00 | €337.47K | €342.30K | €87.08K |
| Free Cash Flow | €-2.62 Million | €2.09 Million | €1.67 Million | €2.71 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | €-380.16K | €-59.42K | €2.16 Million | €-2.58 Million |
| Dividends Paid | — | €0.00 | €0.00 | — |
| Stock-Based Compensation | €0.00 | €226.50K | €1.05 Million | €1.11 Million |
| Depreciation | €60.17K | €57.48K | €226.67K | €189.54K |
| Change in Cash | €6.53 Million | €-1.28 Million | €967.15K | €802.81K |
BRITANNIA LIFE SCIENCES Earnings History — EPS Actual vs. Analyst Estimates
Track BRITANNIA LIFE SCIENCES's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for BRITANNIA LIFE SCIENCES.